Vedolizumab (anti-α4β7-integrin)
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn’s disease.
| Trivial name | Entyvio |
| Catalog Number | A2045 |
| CAS# | 943609-66-3 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/vedolizumab-anti-alpha-4-beta-7-integrin.html |